{"nct_id":"NCT01585272","title":"Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia","status":"COMPLETED","status_verified_date":"2018-04","start_date":"2012-08","start_date_type":null,"primary_completion_date":"2015-06","primary_completion_date_type":"ACTUAL","completion_date":"2015-06","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["NVS"]}